Important goals of our study were therefore to develop tools that can be directly applied to novel missense variations in DSG2-ECD, and to gain further insight into the functional consequences of sequence variations for the development of ARVC. The gene discussed is DSG2; the disease is Arrhythmogenic right ventricular dysplasia.